TP53 and neoplasm: The sequencing analysis of the tumour and CSF samples at relapse revealed common alterations including four predicted drivers: PTCH1:p.L1024Pfs, TP53:p.N239Tfs, CDKN2B:p.G124D and KMT2A:p.W1199S (Fig. 5b).